April 13 (Reuters) - Genfit SA GNFT.PA :
* GENFIT REPORTS FULL-YEAR 2022 FINANCIAL RESULTS AND
PROVIDES
CORPORATE UPDATE
* GENFIT SA - TOPLINE PHASE 3 DATA FOR ELAFIBRANOR IN PBC:
TOWARDS
END OF 2Q23
* GENFIT SA - CASH, CASH EQUIVALENTS, CURRENT FINANCIAL
ASSETS
TOTALED EUR 140.2 MILLION AS OF DEC 31, 2022 EXPECTED TO FUND
OPERATIONS THROUGH Q3 2024
* GENFIT SA - TOPLINE RESULTS FOR ELATIVE STUDY ARE NOW
IMMINENT
AND EXPECTED TO BE ANNOUNCED TOWARDS END OF Q2 OF 2023.
* GENFIT SA - QTRLY LOSS PER SHARE $0.48
Source text for Eikon: ID:nGNX2zzRhd
Further company coverage: GNFT.PA
((Reuters.Brief@thomsonreuters.com;))